Recém-nascidos com risco de toxoplasmose congênita, revisão de 16 anos
DOI:
https://doi.org/10.15448/1980-6108.2018.4.32169Palavras-chave:
transmissão vertical de doença infecciosa, toxoplasmose congênita, coriorretinite, estudos transversais, prevalência.Resumo
OBJETIVOS: Analisar os dados de gestações com risco de toxoplasmose congênita e investigar a evolução dos recém-nascidos, em um hospital de nível II em Portugal.
MÉTODOS: Um estudo transversal retrospetivo incluiu recém-nascidos com risco de toxoplasmose congênita e suas mães, cujo parto ocorreu entre janeiro de 2000 e dezembro de 2015. Os critérios de inclusão foram mãe com soroconversão para toxoplasmose durante a gestação ou primeira amostra sérica com IgM e IgG específicas positivas. O diagnóstico de toxoplasmose congênita foi definido por IgM específica positiva ao nascimento e/ou reação em cadeia da polimerase positiva no líquido amniótico e/ou persistência de IgG específica até os 12 meses de vida. A toxoplasmose congênita foi definida como sintomática quando os achados clínicos foram atribuídos à doença. Os testes Qui-quadrado ou Exato de Fisher foram usados para testar associações entre variáveis, assumindo-se significado estatístico quando p<0,05.
RESULTADOS: Ocorreram 39.585 nascimentos vivos no período em estudo e foram identificados 98 casos com risco de toxoplasmose congênita, dos quais 89 completaram o seguimento. A prevalência de IgG para T. gondii nas gestantes foi de 26% (intervalo de confiança [IC] 95% 24-27%). Foram confirmados 22 casos de toxoplasmose congênita (5,6 por 10.000 nascidos vivos, IC95% 3,5-8,5 por 10.000). Dos 22 recém-nascidos, 18 (82%, IC95% 61-93%) eram sintomáticos. Os achados clínicos mais frequentes foram calcificação intracraniana (64%), hepatomegalia e/ou elevação das transaminases (32%) e retinocoroidite (14%). As lesões cerebrais foram mais frequentes quando a infeção materna foi documentada no primeiro e segundo trimestres em comparação com o terceiro (p=0,018). Em 31 casos (35%), as gestantes foram tratadas desde o momento do diagnóstico até o parto com espiramicina, não se tendo encontrado diferenças relativamente à taxa de transmissão vertical ou ao aparecimento de manifestações clínicas entre os recém-nascidos de mães tratadas e não tratadas.
CONCLUSÕES: A prevalência de toxoplasmose congênita foi superior à reportada em outros países da Europa. A prevalência de calcificações intracranianas foi maior do que a descrita na literatura, enquanto que a de retinocoroidite e estrabismo foi menor. As alterações cerebrais nos recém-nascidos foram mais frequentes nas infecções de primeiro e segundo trimestre. Não houve diferença na taxa de transmissão vertical e na ocorrência de manifestações clínicas entre os recém-nascidos cujas mães receberam espiramicina na gestação ou não receberam tratamento.
Downloads
Referências
Bischoff AR, Friedrich L, Cattan JM, Uberti FAF. Incidence of Symptomatic Congenital Toxoplasmosis During Ten Years in a Brazilian Hospital. Pediatr Infect Dis J. 2016;35(12):1313-6. https://doi.org/10.1097/INF.0000000000001307
Remigton JS, McLeod R, Tulliez P. Toxoplasmosis. In: Remington JS, Klein JO, Wilson CB, Baker CJ., eds. Infectious Diseases of the Fetus and Newborn Infant, Volume 31, 6th edition. United States of America: Saunders Elsevier; 2006:947-1091. https://doi.org/10.1016/B0-72-160537-0/50033-5
McAuley JB, Boyer K, Remington JS, McLeod R. Toxoplasmosis. In: Feigin RD, Cherry J, Demmler-Harrison GJ, Kaplan SL., eds. Feigin and Cherry's Textbook of Pediatric Infectious Diseases, 6th edition. United States of America: Elsevier; 2009:2954-71.
Moncada PA, Montoya JG. Toxoplasmosis in the fetus and newborn: an update on prevalence, diagnosis and treatment. Expert Rev Anti Infect Ther. 2012;10:815-28. https://doi.org/10.1586/eri.12.58
Montoya JG, Remington JS. Management of Toxoplasma gondii infection during pregnancy. Clin Infect Dis. 2008;47:554-66. https://doi.org/10.1086/590149
Guerina NG, Hsu HW, Meissner HC, Maguire JH, Lynfield R, Stechenberg B, Abroms I, Pasternack MS, Hoff R, Eaton RB, Grady GF. Neonatal serologic screening and early treatment for congenital Toxoplasma gondii infection. The New England Regional Toxoplasma Working Group. N Engl J Med. 1994;330(26):1858-63. https://doi.org/10.1056/NEJM199406303302604
Thiébaut R, Leproust S, Chêne G, Gilbert R, SYROCOT (Systematic Review on Congenital Toxoplasmosis) study group. Effectiveness of prenatal treatment for congenital toxoplasmosis: a meta-analysis of individual patients' data. Lancet. 2007;369:115-22. https://doi.org/10.1016/S0140-6736(07)60072-5
Dunn D, Wallon M, Peyron F, Petersen E, Peckham C, Gilbert R. Mother-to-child transmission of toxoplasmosis: risk estimates for clinical counselling. Lancet. 1999;353:1829-33. https://doi.org/10.1016/S0140-6736(98)08220-8
Montoya JG, Liesenfeld O. Toxoplasmosis. Lancet. 2004;363:1965-76. https://doi.org/10.1016/S0140-6736(04)16412-X
Villena I, Ancelle T, Delmas C, Garcia P, Brezin AP, Thulliez P, Wallon M, King L, Goulet V, Toxosurv network and National Reference Centre for Toxoplasmosis. Congenital toxoplasmosis in France in 2007: first results from a national surveillance system. Euro Surveill. 2010;15:19600. https://doi.org/10.2807/ese.15.25.19600-en
Varella IS, Canti IC, Santos BR, Coppini AZ, Argondizzo LC, Tonin C, Wagner MB. Prevalence of acute toxoplasmosis infection among 41,112 pregnant women and the mother-to-child transmission rate in a public hospital in South Brazil. Mem Inst Oswaldo Cruz. 2009;104:383-8. https://doi.org/10.1590/S0074-02762009000200037
Prusa AR, Kasper DC, Pollak A, Gleiss A, Waldhoer T, Hayde M. The Austrian Toxoplasmosis Register, 1992-2008. Clin Infect Dis. 2015;60:e4-10. https://doi.org/10.1093/cid/ciu724
Stagni L, Romano MA, Romano A, Magli A, Briganti F, Del Pezzo MA, Buffolano W. Prenatal screening for congenital toxoplasmosis in Campania: preliminary report on activities and results. Mem Inst Oswaldo Cruz. 2009;104:374-7. https://doi.org/10.1590/S0074-02762009000200035
Gilbert R, Tan HK, Cliffe S, Guy E, Stanford M. Symptomatic toxoplasma infection due to congenital and postnatally acquired infection. Arch Dis Child. 2006;91:495-8. https://doi.org/10.1136/adc.2005.088385
Lebech M, Andersen O, Christensen NC, Hertel J, Nielsen HE, Peitersen B, Rechnitzer C, Larsen SO, Nørgaard-Pedersen B, Petersen E. Feasibility of neonatal screening for toxoplasma infection in the absence of prenatal treatment. Danish Congenital Toxoplasmosis Study Group. Lancet. 1999;353:1834-7. https://doi.org/10.1016/S0140-6736(98)11281-3
Aspock H. Prevention of congenital toxoplasmosis in Austria. Arch Pediatr. 2003;10:16-7.
Antoniou M, Tzouvali H, Sifakis S, Galanakis E, Georgopoulou E, Liakou V, Giannakopoulou C, Koumantakis E, Tselentis Y. Incidence of toxoplasmosis in 5532 pregnant women in Crete, Greece: management of 185 cases at risk. Eur J Obstet Gynecol Reprod Biol. 2004;117:138-43. https://doi.org/10.1016/j.ejogrb.2004.03.001
Nash JQ, Chissel S, Jones J, Warburton F, Verlander NQ. Risk factors for toxoplasmosis in pregnant women in Kent, United Kingdom. Epidemiol Infect. 2005;133:475-83. https://doi.org/10.1017/S0950268804003620
Hung CC, Fan CK, Su KE, Sung FC, Chiou HY, Gil V, da Conceicao dos Reis Ferreira M, de Carvalho JM, Cruz C, Lin YK, Tseng LF, Sao KY, Chang WC, Lan HS, Chou SH. Serological screening and toxoplasmosis exposure factors among pregnant women in the Democratic Republic of São Tome and Principe. Trans R Soc Trop Med Hyg. 2007;101:134-9. https://doi.org/10.1016/j.trstmh.2006.04.012
Liu Q, Wei F, Gao S, Jiang L, Lian H, Yuan B, Yuan Z, Xia Z, Liu B, Xu X, Zhu XQ. Toxoplasma gondii infection in pregnant women in China. Trans R Soc Trop Med Hyg. 2009;103:162-6. https://doi.org/10.1016/j.trstmh.2008.07.008
Portugal. Serviço Nacional de Saúde. Direção-Geral da Saúde. Programa Nacional para a Vigilância da Gravidez de Baixo Risco [Internet]. [cited September 7, 2018]. Available from: https://www.dgs.pt/em-destaque/programa-nacional-para-a-vigilancia-da-gravidez-de-baixo-risco.aspx
Portugal. Serviço Nacional de Saúde. Direção-Geral da Saúde. Exames laboratoriais na Gravidez de Baixo Risco. [Cited September 7, 2018]. Available from: https://www.dgs.pt/directrizes-da-dgs/normas-e-circulares-normativas/norma-n-0372011-de-30092011.aspx
Lito D, Francisco T, Salva I, Tavares MI, Oliveira R, Neto MT. Análise das Serologias para Infeções do Grupo TORCH e do Rastreio para Streptococcus do Grupo B na População de Grávidas de uma Maternidade. Acta Med Port. 2013;26(5):549-54.
Lago EG, Carvalho RL, Jungblut R, Silva VB, Fiori RM. Screening for Toxoplasma gondii antibodies in 2,513 consecutive parturient women and evaluation of newborn infants at risk for congenital toxoplasmosis. Sci Med. 2009;19:27-34.
Costa FF, Gondim APS, Lima MB, Braga JU, Souza Vieira LJE, Araujo MAL. Preventive behavior for toxoplasmosis in pregnant adolescents in the state of Ceara, Brazil. BMC Public Health. 2012;12:73. https://doi.org/10.1186/1471-2458-12-73
Bichara CNC, Canto GAC, Tostes CL, Freitas JJS, Carmo EL, Póvoa MM, Silveira EC. Incidence of congenital toxoplasmosis in the City of Belém, State of Pará, Northern Brazil, determined by a neonatal screening program: preliminary results. Rev Soc Bras Med Trop. 2012;45:122-4. https://doi.org/10.1590/S0037-86822012000100024
Dubey JP, Lago EG, Gennar SM, Su C, Jones JL. Toxoplasmosis in humans and animals in Brazil: high prevalence, high burden of disease, and epidemiology. Parasitology. 2012;139:1375-424. https://doi.org/10.1017/S0031182012000765
Desmonts G, Couvreur J. Congenital toxoplasmosis. A prospective study of 378 pregnancies. N Engl J Med. 1974;290:1110-6. https://doi.org/10.1056/NEJM197405162902003
Naoi K, Yano A. A theoretical analysis of the relations between the risk of congenital toxoplasmosis and the annual infection rates with a convincing argument for better public intervention. Parasitol Int. 2002;51:187-94 https://doi.org/10.1016/S1383-5769(02)00009-0
Lebech M, Joynson DHM, Seitz HM, Thulliez P, Gilbert RE, Dutton GN, Ovlisen B, Petersen E. Classification system and case definitions of Toxoplasma infection in immunocompetent pregnant women and their congenitally infected offspring. Eur J Clin Microbiol Infect Dis. 1996;15:799–805. https://doi.org/10.1007/BF01701522
Mcleod R, Kieffer F, Sautter M, Hosten T, Pelloux H. Why prevent, diagnose and treat congenital toxoplasmosis. Mem Inst Oswaldo Cruz. 2009;104:320-44. https://doi.org/10.1590/S0074-02762009000200029
Prusa AR, Hayde M, Pollak A, Herkner KR, Kasper DC. Evaluation of the liaison automated testing system for diagnosis of congenital toxo- plasmosis. Clin Vaccine Immunol. 2012;19:1859-63. https://doi.org/10.1128/CVI.00489-12
Jaisson-Hot I, Wallon M, Kurdi M, Thulliez P, Kahi S, Cozon G, Peyron F. Congenital toxoplasmosis. Transitory negative serology. Presse Med. 2001;30(20):1001-4
Prusa AR, Kasper DC, Pollak A, Olischar M, Gleiss A, Hayde M. Amniocentesis for the detection of congenital toxoplasmosis: results from the nationwide Austrian prenatal screening program. Clin Microbiol Infect 2015;21:191.e1-8. https://doi.org/10.1016/j.cmi.2014.09.018
Campello Porto L, Duarte EC. Association between the risk of congenital toxoplasmosis and the classification of toxoplasmosis in pregnant women and prenatal treatment in brazil, 1994 – 2009. Int J Infect Dis. 2012;16:e480-6. https://doi.org/10.1016/j.ijid.2012.01.016
Hotop A, Hlobil H, Gross U. Efficacy of rapid treatment initiation following primary Toxoplasma gondii infection during pregnancy. Clin Infect Dis. 2012;54:1545-52. https://doi.org/10.1093/cid/cis234
Wallon M, Peyron F, Cornu C, Vinault S, Abrahamowicz M, Kopp CB, Binquet C. Congenital toxoplasma infection: monthly prenatal screening decreases transmission rate and improves clinical outcome at age 3 years. Clin Infect Dis. 2013;56:1223-31. https://doi.org/10.1093/cid/cit032
Rodrigues IMX, Costa TL, Avelar JB, Amaral WN, Castro AM, Avelino MM. Assessment of laboratory methods used in the diagnosis of congenital toxoplasmosis after maternal treatment with spiramycin in pregnancy. BMC Infect Dis. 2014;14:349. https://doi.org/10.1186/1471-2334-14-349
Sáfadi MAP, Berezin EN, Farhat CK, Carvalho ES. Clinical presentation and follow up of children with congenital toxoplasmosis in Brazil. Braz J Infect Dis. 2003;7:325-33. https://doi.org/10.1590/S1413-86702003000500007
Carvalheiro CG, Mussi-Pinhata MM, Yamamoto AY, Souza CBS, Maciel LMZ. Incidence of congenital toxoplasmosis estimated by neonatal screening: relevance of diagnostic confirmation in asymptomatic newborn infants. Epidemiol Infect. 2005;133:485-549. https://doi.org/10.1017/S095026880400353X
Lago EG, Neto EC, Melamed J, Rucks AP, Presotto C, Coelho JC, Parise C, Vargas PR, Goldbeck AS, Fiori RM. Congenital toxoplasmosis: late pregnancy infections detected by neonatal screening and maternal serological testing at delivery. Paediatr Perinat Epidemiol. 2007;21:525-31. https://doi.org/10.1111/j.1365-3016.2007.00869.x
Melamed J. Contributions to the history of ocular toxoplasmosis in Southern Brazil. Mem Inst Oswaldo Cruz. 2009;104:358-63. https://doi.org/10.1590/S0074-02762009000200032
Vasconcelos-Santos DV, Azevedo DOM, Campos WR, Oréfice F, Queiroz-Andrade GM, Carellos EV, Castro Romanelli RM, Januário JN, Resende LM, Martins-Filho OA, de Aguiar Vasconcelos Carneiro AC, Almeida Vitor RW, Caiaffa WT; UFMG Congenital Toxoplasmosis Brazilian Group. Congenital toxoplasmosis in southeastern Brazil: results of early ophtalmologic examination of a large cohort of neonates. Ophthalmology. 2009;116:2199-205. https://doi.org/10.1016/j.ophtha.2009.04.042
Vilares A, Gargaté MJ, Ferreira I, Martins S, Gomes JP. Molecular and virulence characterization of Toxoplasma gondii strains isolated from humans in Portugal. Parasitol Res. 2017;116(3):979-85. https://doi.org/10.1007/s00436-017-5374-5
Thiebaut R, Leproust S, Chene G, Gilbert R, [The Systematic Review on Congenital Toxoplasmosis Study Group]. Effectiveness of treatment for congenital toxoplasmosis: a meta-analysis of individual patients data. Lancet. 2007;369:115-22. https://doi.org/10.1016/S0140-6736(07)60072-5
Chêne G, Thiébaut R. Options for clinical trials of pre and post-natal treatments for congenital toxoplasmosis. Mem Inst Oswaldo Cruz. 2009;104(2):299-304. https://doi.org/10.1590/S0074-02762009000200025
Di Mario S, Basevi V, Gagliotti C, Spettoli D, Gori G, D'Amico R, Magrini N. Prenatal education for congenital toxoplasmosis (Review). Cochrane Database of Systematic Reviews 2015, Issue 10. Art. No.: CD006171. https://doi.org/10.1002/14651858.CD006171.pub4
Paquet C, Yudin MH, Allen VM, Bouchard C, Boucher M, Caddy S, Castillo E, Money DM, Murphy KE, Ogilvie G, van Schalkwyk S. Toxoplasmosis in pregnancy, prevention, screening, and treatment. J Obstet Gynaecol Can 2013; 35(1 e Suppl A):S1-S7.
Wallon M, Peyron F, Cornu C, Vinault S, Abrahamowicz MC, BonithonKopp C, Binquet C. Congenital toxoplasma infection: monthly prenatal screening decreases transmission rate and improves clinical outcome at age 3 years. Clin Infect Dis. 2013;56(9):1223-31. https://doi.org/10.1093/cid/cit032
Hotop A, Hlobil H, Gross U. Efficacy of rapid treatment initiation following primary Toxoplasma gondii infection during pregnancy. Clin Infect Dis. 2012;54(11):1545-52. https://doi.org/10.1093/cid/cis234
van de Schoondermark Ven E, Camps W, Eskes T, Meuwissen J, Galama J. Effectiveness of spiramycin for treatment of congenital Toxoplasma gondii infection in rhesus monkeys. Antimicrob Agents Chemother. 1994;38:1930-6. https://doi.org/10.1128/AAC.38.9.1930
van de Schoondermark Ven E, Melchers W, Galama J, Camps W, Eskes T, Meuwissen J. Congenital toxoplasmosis: an experimental study in rhesus monkeys for transmission and prenatal diagnosis. Exp Parasitol. 1993;77:200-11. https://doi.org/10.1006/expr.1993.1077
Rodrigues LMX, Castro AM, Gomes MBF, Amaral WN, Avelino MM. Congenital toxoplasmosis: evaluation of serological methods for detection of anti Toxoplasma gondii IgM and IgA antibodies. Mem Inst Oswaldo Cruz. 2009;104:434-40. https://doi.org/10.1590/S0074-02762009000300006
Gilbert R, Freeman K, Lago EG, Bahia-Oliveira LM, Tan HK, Wallon M, Buffolano W, Stanford MR, Petersen E; European Multicentre Study on Congenital Toxoplasmosis (EMSCOT). Ocular Sequelae of congenital toxoplasmosis in Brazil compared with Europe. PLoS Negl Trop Dis. 2008;2(8):e277. https://doi.org/10.1371/journal.pntd.0000277
Kieffer F, Wallon M, Garcia P, Thulliez P, Peyron F, Franck J. Risk factors for retinochoroiditis during the first 2 years of life in infants with treated congenital toxoplasmosis. Pediatr Infect Dis J. 2008;27:27-32. https://doi.org/10.1097/INF.0b013e318134286d
Lebech M, Andersen O, Christensen NC, Hertel J, Nielsen HE, Peitersen B, Rechnitzer C, Larsen SO, Nørgaard-Pedersen B, Petersen E. Feasibility of neonatal screening for toxoplasma infection in the absence of prenatal treatment. Lancet. 1999;353:1834-7. https://doi.org/10.1016/S0140-6736(98)11281-3
Lago EG, Oliveira AP, Bender AL. Presence and duration of anti-Toxoplasma gondii immunoglobulin M in infants with congenital toxoplasmosis. J Pediatr (Rio J). 2014;90(4):363-9. https://doi.org/10.1016/j.jped.2013.12.00
Downloads
Publicado
Como Citar
Edição
Seção
Licença
Copyright (c) 2018 Scientia Medica
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.
Direitos Autorais
A submissão de originais para a Scientia Medica implica na transferência, pelos autores, dos direitos de publicação. Os direitos autorais para os artigos publicados nesta revista são do autor, com direitos da revista sobre a primeira publicação. Os autores somente poderão utilizar os mesmos resultados em outras publicações indicando claramente a Scientia Medica como o meio da publicação original.
Licença Creative Commons
Exceto onde especificado diferentemente, aplicam-se à matéria publicada neste periódico os termos de uma licença Creative Commons Atribuição 4.0 Internacional, que permite o uso irrestrito, a distribuição e a reprodução em qualquer meio desde que a publicação original seja corretamente citada.
